Does Dr. JANELLE VANDE GRIEND have financial conflicts of interest?

Dr. JANELLE VANDE GRIEND (APRN-CPNP) has received a total of $275 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $275 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. JANELLE VANDE GRIEND?

According to CMS Open Payments data, Dr. JANELLE VANDE GRIEND received funding from SOLVENTUM CORPORATION ($180) and TAKEDA PHARMACEUTICALS U.S.A ($96).

Does Dr. JANELLE VANDE GRIEND receive research grants or speaking fees?

Dr. JANELLE VANDE GRIEND has received $275 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. JANELLE VANDE GRIEND

APRN-CPNPReal-Time Hydrated

Specialty: Nurse Practitioner

Practice Location: SIOUX FALLS, SD 57105

NPI Number: 1033711544

LIFETIME INDUSTRY VALUE

$275

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. VANDE GRIEND is a verified Nurse Practitioner practitioner based in SIOUX FALLS, SD.

Between 2021 and 2025, Dr. VANDE GRIEND had an overall industry promotional and research financial footprint of $275 as recorded in the federal CMS Open Payments database.

$275 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. VANDE GRIEND's primary funding source is SOLVENTUM CORPORATION, which accounts for $180 (representing 65.3% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

SOLVENTUM CORPORATION

Rank 1

$180

65.3%

TAKEDA PHARMACEUTICALS U.S.A

Rank 2

$96

34.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.